A breast-cancer specialist at Fudan University Shanghai Cancer Center, with public work in clinical care and molecular classification of breast cancer.
Professional background
The hospital’s 2019 profile and 2022 report on Shao Zhimin and Jiang Yizhou’s team document his breast-cancer background, including triple-negative breast-cancer research.
This introduction describes published professional work. The hospital confirms the current role, consultation language, appointment location and availability for your enquiry.
This information helps you prepare for a clinical conversation. It does not establish a diagnosis, treatment eligibility or a confirmed booking. A listed hospital or clinician is not a claim of partnership. Seek local urgent care for an emergency.
Sources and references
Related conditions and questions
Breast cancer
Breast cancer includes diseases with different stages and tumour characteristics. A breast-team review brings pathology, imaging and previous treatment together before discussing a plan.
Triple-negative breast cancer
Triple-negative breast cancer lacks the hormone-receptor and HER2 features used to select some breast-cancer treatments. The term does not by itself establish stage or an individual treatment plan.
Recurrent or metastatic breast cancer
Breast cancer may recur near the original site or spread to distant organs. These situations differ, so a review first clarifies where the disease is now and what treatment has already been used.
You don’t have to figure it out alone.
Tell us what you need help with. Your first conversation is free, and there’s no need to have every document ready.